Category:Bcr-Abl inhibitors
Drugs that inhibit Bcr-Abl, the constitutively active tyrosine kinase resulting from the Philadelphia chromosome 9:22 translocation seen in chronic myelogenous leukemia (CML) and some acute lymphocytic leukemias (ALL).
Pages in category "Bcr-Abl inhibitors"
The following 7 pages are in this category, out of 7 total.
